PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

97 hedge funds and large institutions have $73.9M invested in Invesco Biotechnology & Genome ETF in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+1
Holders Change %
+1.04%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
16
Reduced
31
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GKWIM
1
Gerber Kawasaki Wealth & Investment Management
California
$15.8M
2
PIM
2
Penobscot Investment Management
Massachusetts
$562K
3
Citadel Advisors
3
Citadel Advisors
Florida
$510K
4
UBS Group
4
UBS Group
Switzerland
$5.38M
5
Wealth Enhancement Advisory Services
5
Wealth Enhancement Advisory Services
Minnesota
$315K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$11.8M
2
M&T Bank
2
M&T Bank
New York
$583K
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
SIA
4
SkyView Investment Advisors
New Jersey
$0
5
PWM
5
PRW Wealth Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CWA
101
Clearview Wealth Advisors
Oregon
– -$9.19K -150 Closed
CCM
102
Chilton Capital Management
Texas
– -$8.03K -131 Closed
PTC
103
Private Trust Company
Ohio
– -$7.66K -125 Closed
PO
104
Private Ocean
California
– -$490 -8 Closed
1 2 3 4
5